Hisano, H. | Search bioRxiv

bioRxiv2025

Evolution of HMA-integrated tandem kinases accompanied by expansion of target pathogens

Tandem kinase proteins (TKPs) are an emerging family of plant intracellular immune receptors that offer potential for developing novel disease resistance. We cloned Rmo2 and Rwt7, genes for resistance to the blast fungus, from barley and wheat, respectively, and discovered that they are orthologs encoding TKPs with an integrated N-terminal heavy metal-associated (HMA) domain. Rmo2 was collocated with Rpg1, a TKP gene for resistance to stem rust, while Rwt7 was collocated with WTK4, a TKP gene for resistance to powdery mildew. Domain swapping suggested that the HMA domain determines target effector specificity of these genes. We propose a model illustrating an evolutionary process in which a TKP gene has differentiated into paralogs and orthologs that recognize various effectors through diversification of their HMA domains.

plant biology↗

bioRxiv2025

Structure-guided development of a potent human B0AT1 inhibitor effective in a mouse model of phenylketonuria

B0AT1 is a neutral amino acid transporter responsible for the (re)absorption in the intestine and kidney. Here, we developed small-molecule inhibitors of B0AT1 as a therapeutic strategy to a transient pocket, located [~]17 [A] away from the substrate-binding site and unique to the outward-open conformation, and stabilize an outward-occluded conformation that prevents the conformational transitions required for transport. Guided by structural insights, we optimized an initial inhibitor (Cinromide) to improve potency and cross-species activity, yielding compound 3, which inhibits both human and mouse B0AT1 with submicromolar IC_50 values. In a PKU mouse model (Pahenu2), oral administration of compound 3 increased urinary Phe excretion and significantly reduced plasma Phe. Our findings identify a druggable allosteric site in B0AT1, demonstrate its utility for achieving potent and selective inhibition in vivo, and establish allosteric blockade as a therapeutic approach for PKU and other SLC6-family transporters.

pharmacology and toxicology↗